Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-05-018549
Filing Date
2005-04-01
Accepted
2005-04-01 20:16:11
Documents
1
Period of Report
2005-03-31

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION bny07472_bny001cel.html 4  
1 MAIN DOCUMENT DESCRIPTION bny07472_bny001cel.xml 4 5228
  Complete submission text file 0001209191-05-018549.txt   7258
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Reporting) CIK: 0000816284 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-20713 | Film No.: 05727280
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9640 MEDICAL CNTR SR STE 200 ROCKVILLE MD 20850
Business Address 9640 MEDICAL CNTR DR STE 200 ROCKVILLE MD 20850 3012179858
ENTREMED INC (Issuer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)